application): This project will undertake the development of novel methods to analyze the structures of macromolecules that their complexes using energy based models, focusing primarily on electrostatic interactions. One of the fundamental difficulties in understanding the energetics of binding is that most of the interactions are exchange reactions; that is, chemical groups trade interactions with solvent in the unbound state for interactions with the binding partner in the bound state. A novel innovation introduced here is the definition of an electrostatic complement, the optimal tradeoff between unfavorable desolvation energy and favorable interactions in the complex. This essentially inverts the design problem, designing the properties of the optimal based on physical principles, and provides a clear and precise standard that can be compared to trial ligands and that can be used as a template in the modification of existing ligands and the de novo construction of new ligands. The PI has developed methods to solve, for this complement, using simplified geometrics.
The aim i s to extend those methods to arbitrarily shaped molecules, to develop methods for using the optimal electrostatic complement in ligand discovery, and to extend current methods for the analysis of conformationally flexible ligands. The methods will be tested and validated initially using the well- characterized class II MHC molecule and the HIV protease. Further design efforts will proceed with other targets characterized within this program.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM056552-04
Application #
6336556
Study Section
Project Start
2000-08-01
Project End
2001-07-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
4
Fiscal Year
2000
Total Cost
$222,021
Indirect Cost
Name
Whitehead Institute for Biomedical Research
Department
Type
DUNS #
076580745
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Suntoke, Tara R; Chan, David C (2005) The fusion activity of HIV-1 gp41 depends on interhelical interactions. J Biol Chem 280:19852-7
Koshiba, Takumi; Chan, David C (2003) The prefusogenic intermediate of HIV-1 gp41 contains exposed C-peptide regions. J Biol Chem 278:7573-9
Klein, R Matthew; Zheng, Mingzhe; Ambesi, Anthony et al. (2003) Stimulation of extracellular matrix remodeling by the first type III repeat in fibronectin. J Cell Sci 116:4663-74
Sia, Samuel K; Kim, Peter S (2003) Protein grafting of an HIV-1-inhibiting epitope. Proc Natl Acad Sci U S A 100:9756-61
Dayie, Kwaku T; Brodsky, Alexander S; Williamson, James R (2002) Base flexibility in HIV-2 TAR RNA mapped by solution (15)N, (13)C NMR relaxation. J Mol Biol 317:263-78
Carlomagno, Teresa; Hennig, Mirko; Williamson, James R (2002) A novel PH-cT-COSY methodology for measuring JPH coupling constants in unlabeled nucleic acids. application to HIV-2 TAR RNA. J Biomol NMR 22:65-81
Sarkar, Casim A; Lowenhaupt, Ky; Horan, Thomas et al. (2002) Rational cytokine design for increased lifetime and enhanced potency using pH-activated ""histidine switching"". Nat Biotechnol 20:908-13
Hennig, M; Carlomagno, T; Williamson, J R (2001) Residual dipolar coupling TOCSY for direct through space correlations of base protons and phosphorus nuclei in RNA. J Am Chem Soc 123:3395-6
Root, M J; Kay, M S; Kim, P S (2001) Protein design of an HIV-1 entry inhibitor. Science 291:884-8
Lee, L P; Tidor, B (2001) Optimization of binding electrostatics: charge complementarity in the barnase-barstar protein complex. Protein Sci 10:362-77

Showing the most recent 10 out of 23 publications